The #ISNWCN abstracts are now live in the @KIreport supplement! 📖✨ ➡️ www.kireports.org/issue/S2468-...
Proud to be part of this journey—see you in Delhi! 🇮🇳💙 @theisn.org
Proud to be part of this journey—see you in Delhi! 🇮🇳💙 @theisn.org
January 27, 2025 at 4:41 PM
The #ISNWCN abstracts are now live in the @KIreport supplement! 📖✨ ➡️ www.kireports.org/issue/S2468-...
Proud to be part of this journey—see you in Delhi! 🇮🇳💙 @theisn.org
Proud to be part of this journey—see you in Delhi! 🇮🇳💙 @theisn.org
"The activation of the #complement system is not necessarily harmful in all settings, and hence #complementinhibition is not necessarily beneficial in all conditions."
#kireport
The Rational Use of Complement Inhibitors in Kidney Diseases
kireports.org/article/S2468-…
#kireport
The Rational Use of Complement Inhibitors in Kidney Diseases
kireports.org/article/S2468-…
The Rational Use of Complement Inhibitors in Kidney Diseases
The development of complement inhibitors represented one of the major breakthroughs in clinical nephrology in the last decade. Complement inhibition has dramatically transformed the outcome of one of the most severe kidney diseases, the atypical hemolytic uremic syndrome (aHUS), a prototypic complement-mediated disorder. The availability of complement inhibitors has also opened new promising perspectives for the management of several other kidney diseases in which complement activation is involved to a variable extent.
www.kireports.org
March 28, 2025 at 3:12 AM
"The activation of the #complement system is not necessarily harmful in all settings, and hence #complementinhibition is not necessarily beneficial in all conditions."
#kireport
The Rational Use of Complement Inhibitors in Kidney Diseases
kireports.org/article/S2468-…
#kireport
The Rational Use of Complement Inhibitors in Kidney Diseases
kireports.org/article/S2468-…
📯📢 Can't Echo it enough: Continuation of ACEi and ARB💯 #Kireport #isnkidneycare #theisn #RAASiToolkit
x.com/Kidney_Int/sta…
x.com/Kidney_Int/sta…
March 28, 2025 at 3:46 AM
📯📢 Can't Echo it enough: Continuation of ACEi and ARB💯 #Kireport #isnkidneycare #theisn #RAASiToolkit
x.com/Kidney_Int/sta…
x.com/Kidney_Int/sta…
⏰⏳"Time has come to adopt an #antigen-based classification of #MN b/c this approach will allow for accurate and specific MN diagnosis, with significant implications for patient management and targeted treatment#kireport #theisn #membranousnephropathy
kidney-international.org/article/S0085-…
kidney-international.org/article/S0085-…
March 28, 2025 at 3:46 AM
⏰⏳"Time has come to adopt an #antigen-based classification of #MN b/c this approach will allow for accurate and specific MN diagnosis, with significant implications for patient management and targeted treatment#kireport #theisn #membranousnephropathy
kidney-international.org/article/S0085-…
kidney-international.org/article/S0085-…
"The activation of the #complement system is not necessarily harmful in all settings, and hence #complementinhibition is not necessarily beneficial in all conditions."
#kireport
The Rational Use of Complement Inhibitors in Kidney Diseases
kireports.org/article/S2468-…
#kireport
The Rational Use of Complement Inhibitors in Kidney Diseases
kireports.org/article/S2468-…
The Rational Use of Complement Inhibitors in Kidney Diseases
The development of complement inhibitors represented one of the major breakthroughs in clinical nephrology in the last decade. Complement inhibition has dramatically transformed the outcome of one of the most severe kidney diseases, the atypical hemolytic uremic syndrome (aHUS), a prototypic complement-mediated disorder. The availability of complement inhibitors has also opened new promising perspectives for the management of several other kidney diseases in which complement activation is involved to a variable extent.
www.kireports.org
March 28, 2025 at 3:39 AM
"The activation of the #complement system is not necessarily harmful in all settings, and hence #complementinhibition is not necessarily beneficial in all conditions."
#kireport
The Rational Use of Complement Inhibitors in Kidney Diseases
kireports.org/article/S2468-…
#kireport
The Rational Use of Complement Inhibitors in Kidney Diseases
kireports.org/article/S2468-…
📯📢 Can't Echo it enough: Continuation of ACEi and ARB💯 #Kireport #isnkidneycare #theisn #RAASiToolkit
x.com/Kidney_Int/sta…
x.com/Kidney_Int/sta…
March 28, 2025 at 3:21 AM
📯📢 Can't Echo it enough: Continuation of ACEi and ARB💯 #Kireport #isnkidneycare #theisn #RAASiToolkit
x.com/Kidney_Int/sta…
x.com/Kidney_Int/sta…
⏰⏳"Time has come to adopt an #antigen-based classification of #MN b/c this approach will allow for accurate and specific MN diagnosis, with significant implications for patient management and targeted treatment#kireport #theisn #membranousnephropathy
kidney-international.org/article/S0085-…
kidney-international.org/article/S0085-…
March 28, 2025 at 3:21 AM
⏰⏳"Time has come to adopt an #antigen-based classification of #MN b/c this approach will allow for accurate and specific MN diagnosis, with significant implications for patient management and targeted treatment#kireport #theisn #membranousnephropathy
kidney-international.org/article/S0085-…
kidney-international.org/article/S0085-…